QC Kinetix

QC Kinetix

Franzy VerifiedInformation based on 2025 FDD

Health & Wellness · Alternative Care

Investment min
$250K
Total: $250K–$500K
Avg gross revenue
$850K
Unit-level, 2025
Franchise fee
$55K
Veteran discount available
Royalty
8%
of gross revenue
Locations
153
Franchising since 2020

Description

What is QC Kinetix?

QC Kinetix is a revolutionary healthcare franchise at the forefront of regenerative medicine and non-surgical pain treatment. Founded in 2017, the company has rapidly expanded across the United States, offering innovative solutions for those seeking alternatives to traditional surgery and medication-based treatments.

The franchise specializes in using cutting-edge regenerative medicine techniques, including stem cell therapy, platelet-rich plasma (PRP), and other advanced biological treatments to help patients overcome joint pain, sports injuries, and chronic conditions. Their approach focuses on harnessing the body's natural healing abilities to promote recovery and restore mobility.

What sets QC Kinetix apart is their commitment to personalized care and comprehensive treatment plans. Their medical professionals work closely with each patient to develop customized solutions for various conditions, including knee pain, arthritis, shoulder injuries, and back problems. The franchise has garnered numerous positive reviews from patients who have experienced significant pain reduction and improved quality of life without invasive surgery.

The brand maintains high standards of professionalism and medical expertise across all locations, ensuring consistent quality care. Their state-of-the-art facilities are equipped with the latest medical technology, and their staff receives ongoing training in the most advanced regenerative medicine techniques.

For entrepreneurs interested in the healthcare sector, QC Kinetix offers a unique opportunity to enter the rapidly growing field of regenerative medicine. The franchise provides comprehensive support, including medical training, marketing assistance, and operational guidance, making it an attractive option for those looking to make a meaningful impact in healthcare while building a successful business.
  • Non-surgical regenerative medicine leader
  • 194 locations nationwide
  • Drug-free pain management solutions
  • Board-certified medical professionals
  • Cutting-edge ultrasound technology
  • Revenue exceeds sector averages

Location Analysis

Where QC Kinetix wins

Geographic concentration in the Southeast, Texas, Florida, and growing Midwest presence reflects strategic targeting of aging, affluent populations with cultural acceptance of alternative medicine and cash-pay healthcare models. Markets like Charlotte, Nashville, Tampa, and Dallas-Fort Worth align well with the stated demographic profile: suburban affluence (median income $70K+), high baby boomer/early Gen X concentration (45-75 age cohort), and established medical infrastructure creating co-location opportunities near orthopedic and pain management practices. The site selection criteria—medical office placement in 1,500-2,500 sq ft, high visibility near medical clusters, ground-floor accessibility—demonstrates operationally sound thinking for mobility-limited patients seeking non-surgical interventions. However, review sentiment patterns present a substantial territory-level concern. Consistent complaints about sales pressure, treatment costs, and efficacy disappointment suggest customer acquisition will heavily depend on continuous new patient generation rather than referrals or repeat business. This fundamentally alters territory economics and requires evaluation of local competitive intensity, demographic depth, and media cost efficiency. BBB complaints regarding billing disputes indicate potential regulatory or consumer protection scrutiny in certain markets. Prospective franchisees should conduct granular local reputation audits, assess competitive saturation of regenerative medicine providers, and validate referral network viability with local orthopedic and physical therapy practices before committing. Territory exclusivity terms and demographic density become critical success factors given limited customer lifetime value indicated by review patterns.
Total US locations
194
Franchise units
153
Corporate locations
14
Avg. sq. footage
2,000 sq. ft.

Loading map...

Territory check

Is your territory available?

Let's find out.

try

We'll take you through a few quick questions, then QC Kinetix confirms availability directly.

Availability

Financial Analysis

The numbers behind QC Kinetix

Avg gross revenue$850,000
Investment range$250,000 – $500,000
Investment midpoint$375,000
Brand fund1%
Royalty8%
Franchise fee$55,000
Min. net worth$1,000,000
Min. liquid capital$400,000

Veteran discount available

QC Kinetix participates in a veteran discount program on the franchise fee. Ask your Franzy advisor or the brand for current eligibility and terms.

QC Kinetix presents an unusual profile for investor consideration: rapid expansion to 194 units since 2020 indicates strong franchisee recruitment and initial market appetite for regenerative medicine positioning. The $250,000-$500,000 investment range positions this as a mid-tier healthcare franchise, while reported gross revenue of $850,000 suggests potentially viable unit economics if operating expenses align with typical medical service models. However, the cash-pay business model creates significant revenue volatility and customer acquisition challenges absent from insurance-reimbursed healthcare franchises. The 2.1-2.8 star average rating across major platforms represents a critical operational risk—substantially below the 4.0+ benchmark expected in healthcare services—and suggests systemic issues with customer satisfaction that directly threaten repeat business and referral generation. High-volume negative reviews citing aggressive sales tactics, disputed refunds, and efficacy concerns indicate potential brand liability and local marketing headwinds. Treatment protocols priced at $3,000-$7,500+ require consistent conversion rates and patient retention that appear challenged by current satisfaction metrics. Franchisees face the dual burden of medical service delivery complexity and retail-like sales performance requirements, compounded by reputational management in local markets. The regenerative medicine sector's limited insurance coverage and evolving regulatory landscape add medium-term uncertainty to revenue sustainability and competitive positioning.
Did you know? QC Kinetix operates in the Health & Wellness sector's Alternative Care subsector, offering regenerative medicine treatments through a cash-pay model. The initial investment ranges from $250,000 to $500,000, positioning this as a mid-tier healthcare franchise opportunity. Franchise fee information was not disclosed. Founded in 2020, the brand has expanded rapidly to 194 units, primarily concentrated in Southeast and Southwest markets targeting affluent, aging demographics seeking non-surgical pain management solutions.

Financing partners

Vetted partners, tailored to franchisees

Your Franzy advisor can connect you with these partners later in the process — competitive rates, specialized in franchise financing.

FranFund

Lender

CRF USA

Nonprofit SBA lender; provides financing for franchise acquisitions, startups, and expansion.

Lender

First Bank of the Lake

Lender

Pension Pros

Lender

The model

How QC Kinetix works

01
Ownership
Part-Time (Executive)

Owner stays in an executive role — sets strategy, hires a manager, and oversees crews. Typically 5–20 hr/wk after ramp; many keep their day job.

Full-Time

Owner runs the business as their primary job — leads the team day-to-day on the ground, 40+ hr/wk.

02
Revenue
Recurring revenueTransaction-basedBig-ticket salesService-basedProduct sales (retail)Hybrid model
03
Customer
B2B

Sells to businesses, contractors, or property owners.

B2C

Sells directly to consumers and homeowners.

Mixed

Serves both businesses and consumers.

FDD Item 7

Initial investment range

$250K–$500K
Most common
$250,000
Minimum
$375,000
Midpoint
$500,000
Maximum

Per FDD Item 7, total initial investment ranges from $250,000 to $500,000. The midpoint $375,000 is what most franchisees report at signing — financing typically reduces cash-at-close by 80–90%. Knowing the investment range helps you plan confidently and ensure you're fully prepared to make the leap.

FDD Item 19

Average gross sales

$1M$800K$600K$400K$200KN/A
$841K
$806K
$759K
2022
2023
2024
Avg
$802K
YOY change (2023 -> 2024)
-6%

According to Item 19 of the Franchise Disclosure Document, QC Kinetix has an average gross revenue of $759K. (Note: This information is based on the latest FDD in our records. Please review the Franchise Disclosure Document (FDD) and confirm this information directly with the brand. We make no claims of accuracy for the information presented.)

Growth over time

Franchise footprint

+15% YoY
250200150100500
2017
2018
2019
2020
2021
2022
2023
2024
194 units open as of 2025 FDD+25 in last 12 mo

2025 Franchise Disclosure

FDD documents

Below are items 2, 3, 4, 7, 11 and 19 for QC Kinetix's 2025 FDD. The complete FDD is delivered to you directly by the franchisor, per the FTC Franchise Rule.

Estimated initial investment
FDD Item 7 · PDF
Financial performance representations
FDD Item 19 · PDF
Members-only items
Executive team
FDD Item 2 · PDF
Litigation
FDD Item 3 · PDF
Bankruptcy
FDD Item 4 · PDF
Franchisor assistance
FDD Item 11 · PDF
Members only
Unlock the 2025 FDD

Connect to download Items 2, 3, 4, and 11 — direct from the franchisor.

Buyer FAQs

Frequently asked questions

The initial investment for a QC Kinetix franchise typically ranges between $250,000.00 and $500,000.00. This includes the franchise fee, equipment, real estate, and other startup costs. To get a detailed breakdown and better understand the financial requirements, we recommend scheduling a call with the Franzy team. We'll walk you through the specifics and answer any questions you might have. For more detailed information, refer to the financial sections of the FDD.

Disclaimer. The information provided on this page is based on the latest Franchise Disclosure Document (FDD) we have on record, which was issued in 2025. This information is for informational purposes only and is not intended to constitute legal, financial, or business advice. We make no guarantees or claims regarding the completeness or accuracy. Only the franchisor can confirm that the information is complete and accurate and we recommend consulting the franchisor directly for the most recent FDD and regarding any questions that you may have about the information provided.

QC Kinetix
QC Kinetix
$850K avg revenue · 153+ US franchises

Franchises for you

Other brands in the same vertical and investment band — recommendations based on what you've explored.

Franchisor Image
Franzy Verified

Starz Program

Health & Wellness

Gross Revenue$10,007
Min Investment$39,000
Founded2005
Franchise Units14+
Franchisor Image
Franzy Verified

Kellen Mental Health

Health & Wellness

Gross Revenue$618,456
Min Investment$141,850
Founded2024
Franchise UnitsN/A
Franchisor Image
Franzy Verified

Freeform Chiropractic

Health & Wellness

Gross Revenue$903,108
Min Investment$379,700
Founded2022
Franchise Units7+
Franchisor Image
Franzy Verified

Reach7 Diabetes Studio

Health & Wellness

Gross RevenueN/A
Min Investment$429,110
Founded2025
Franchise UnitsN/A
Franchisor Image
Franzy Verified

Foot Solutions

Health & Wellness

Gross Revenue$464,898
Min Investment$163,037
Founded2000
Franchise Units50+
Franchisor Image
Franzy Verified

Essential Speech & ABA Therapy

Health & Wellness

Gross Revenue$1,393,273
Min Investment$299,000
Founded2022
Franchise Units12+
Franchisor Image
Franzy Verified

Evolve Social Wellness

Health & Wellness

Gross Revenue$601,649
Min Investment$631,859
Founded2023
Franchise Units1+
Franchisor Image
Franzy Verified

Pause

Health & Wellness

Gross Revenue$1,789,882
Min Investment$880,600
Founded2022
Franchise Units7+